2004
DOI: 10.1358/dnp.2004.17.3.829015
|View full text |Cite
|
Sign up to set email alerts
|

Mechanism-based therapies for pain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0
3

Year Published

2006
2006
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(10 citation statements)
references
References 0 publications
0
7
0
3
Order By: Relevance
“…Importantly, contralateral intra-hippocampal TNF nanoplex injection decreased CCI-induced bioactive TNF levels (in contralateral hippocampus and ipsilateral sciatic nerve) and completely alleviated thermal hyperalgesia, as well as delayed development of mechanical allodynia. Since hyperalgesia and allodynia differ for time of onset and TNF nanoplex therapy was more effective for hyperalgesia than allodynia, these findings suggest that thermal hyperalgesia and mechanical allodynia are separate mechanisms [1, 5]. However, our findings support that both symptoms of chronic pain syndromes require hippocampal TNF production.…”
Section: Discussionmentioning
confidence: 51%
“…Importantly, contralateral intra-hippocampal TNF nanoplex injection decreased CCI-induced bioactive TNF levels (in contralateral hippocampus and ipsilateral sciatic nerve) and completely alleviated thermal hyperalgesia, as well as delayed development of mechanical allodynia. Since hyperalgesia and allodynia differ for time of onset and TNF nanoplex therapy was more effective for hyperalgesia than allodynia, these findings suggest that thermal hyperalgesia and mechanical allodynia are separate mechanisms [1, 5]. However, our findings support that both symptoms of chronic pain syndromes require hippocampal TNF production.…”
Section: Discussionmentioning
confidence: 51%
“…In contrast to heavy involvement of inflammatory mediators in pain mechanisms [64], given the redundancy in and robustness of the immune system, expectation of profound analgesia by antagonizing a single mediator appears impracticable.…”
Section: Therapeutic Opportunitiesmentioning
confidence: 99%
“…[137] Molecular mechanisms in pain perception[138] will direct mechanism-based drug therapy prescription[139] in palliative care, whereas mechanism-based understanding will direct physical therapy treatment decision-making and efficient treatment delivery in patients with cancer pain. Pain relieving therapy should always accompany disease-modifying therapy and can never substitute the latter.…”
Section: Discussionmentioning
confidence: 99%